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Autonomic nervous system blockades
The aim of this study was to characterize the cardiac autonomic nervous system 
(ANS) through Morlet wavelet transforms of heart rate variability (HRV) and 
compare to Fast Fourier Transform (FFT) analysis. Cardiac sympathetic and 
parasympathetic blockades were studied in conscious rats. Morlet and FFT were 
performed in (1) high-frequency band (HF: 0.6 to 3 Hz), (2) mid-frequency band 
(MF: 0.3 to 0.6 Hz), and (3) low-frequency band (LF: 0.07 to 0.3 Hz). While cardiac 
sympathetic inhibition with metoprolol did not alter average HR, Morlet normalized 
power indices were able to detect it with the highest level of signiﬁcance in LF. 
FFT HRV indices detected only parasympathetic blockade eﬀects in LF and MF 
of the HRV, which accompanied the increase in the average HR. Thus, alterations 
of cardiac ANS may be sensitively detected through Morlet wavelet of HRV while 
average HR is not altered.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article 
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The investigation of heart rate oscillations has received increasing interest as it provides a mea-
sure of autonomic nervous system (ANS) activity [1]. Evaluation of ANS tone through non-invasive 
heart rate variability (HRV) is desired in clinical practice in order to achieve individualized complex-
ity analysis [2]. The mostly used algorithms for analysis of heart rate variability (HRV) to evaluate 
the ANS are linear algorithms based on spectral analysis. The resulting frequency domain indexes are 
commonly used to evaluate the contribution on HRV of ANS. Spectral Fast Fourier transform-based 
method is useful for signals that are stationary in time, since both the time and frequency resolutions 
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of the transform are ﬁxed over the entire time-frequency plane. Morlet wavelet transformation has ad-
vantages over traditional Fourier transforms for accurately decomposing and reconstructing ﬁnite, non-
periodic, and non-stationary signals [3]. Here, we aimed at employing the Morlet-wavelet transforms 
to characterize the HRV indices relative to the baseline sympathetic and parasympathetic components 
of ANS.
2. Methods
All procedures complied with guidelines from the American Physiological Society, and institutional re-
view board approved the study. Male Sprague–Dawley (SD) rats underwent implantation of polyethylene 
catheters into the femoral artery (to monitor arterial pressure and heart rate) and femoral vein (for i.v. 
injection of drugs), which were exteriorized in the interscapular area, as previously described [4]. Six rats 
per group for each drug were used.
The eﬀects of the peripheral muscarinic (methylatropine, 0.5 mg/kg) and β1-adrenergic (metoprolol, 
1 mg/kg) blockers were investigated in freely moving and unstressed rats. Intrafemoral blood pressure was 
sampled at 4 Hz. The time window after drug administration was divided in two windows of 30 min: the 
ﬁrst window including the initial period of lag-time of drug administration with altering hemodynamics, 
and the second window when the drug eﬀect reached its peak (peak-time) in a plateau with hemodynamics 
stabilized.
2.1. Frequency domain analyses
For the frequency domain analyses, the heart rate beat-to-beat (N–N) intervals data were transformed 
into binary sequences with a bin width of 1 ms (zeros and ones time series of 1000 Hz) sampling rate [5,6]. 
Three diﬀerent frequency bands were considered as previously used [7]: (1) a high-frequency band (HF: 0.6 
to 3 Hz), (2) a mid-frequency band (MF: 0.3 to 0.6 Hz), and (3) a low-frequency band (LF: 0.07 to 0.3 Hz).
Variables were calculated both using Fourier and wavelet analysis. Band normalized power was used to 
quantify frequency domain characteristics of the collected data.
2.2. Fourier analysis
Fourier power spectrum was estimated using the fast Fourier transform with a resolution of 0.03 Hz 
(sampling frequency = 1000 samples/s and window size = 30 000 with 50% overlap; Fig. 1) using an algorithm 
developed by Francois Meyer (Copyright©, 2002–2003), as previously described [7].
202 O.P. Neto et al. / Appl. Comput. Harmon. Anal. 40 (2016) 200–206Fig. 2. An example of the scale-averaged Morlet wavelet power spectrum calculated from the N–N data.
2.3. Morlet wavelet analysis
For the wavelet analysis, wavelet power spectrums were calculated using Morlet wavelet transform and 
Matlab functions [8]. Morlet wavelet represents a set of functions with the form of small waves created by 






where η is dimensionless time and w0 is dimensionless frequency (in this study we used w0 = 6, as previously 
used by us [9].
We quantiﬁed the scale-averaged wavelet power spectrum (SAWPS; Fig. 1) as the weighted modulus of 








where W X(s, τ) is the wavelet transform of X(t) (acceleration), which is obtained by dilating and translating 
the mother wavelet (Addison 2002), s represents the dilation parameter (scale shifting), and τ represents the 
location parameter (time shifting). For the w0 = 6 Morlet wavelet the scale is almost equal to the Fourier 
period (Fourier period = 1.03 s) (Fig. 2).
To measure the relative importance of diﬀerent frequency bands, we deﬁned the normalized wavelet 
scale-averaged power spectrum as the squared weighted modulus of the wavelet transform normal-
ized by the sum of the squared weighted modulus over all scales for each instant to time as pro-
posed by us [9]. The normalized wavelet scale-averaged power spectrum shows the relative importance 
through time of each scale (can be related to a frequency) of the signal with intensities ranging from 
0–100%.
3. Statistical analysis
Statistics were performed using GraphPad Prism version 6.0e for Mac OS X, GraphPad Software, 
La Jolla California USA, www.graphpad.com. RM one-way ANOVA, with the Greenhouse–Geisser cor-
rection followed by uncorrected Fishers LSD, with individual variances computed for each compari-
son. Diﬀerences were considered signiﬁcant when the probability of a Type I error was lower than 5% 
(p < 0.05).
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Eﬀects of metoprolol (β-adrenoceptor antagonist) on Morlet transform and Fast Fourier transform of 
heart rate variability.
Metoprolol (β-adrenoceptor antagonist) did not aﬀect signiﬁcantly heart rate, while the arterial pressure 
decreased signiﬁcantly (Fig. 3a).
Morlet wavelet transform indices detected the peak time of metoprolol sympathetic blockade, as these 
were signiﬁcantly altered in comparison with the baseline values and also with the lag time after drug 
administration (Fig. 3b). These Morlet HRV indices were able to detect the cardiac sympathetic inhibition 
at all frequency domain analyses studied (Fig. 3b, left panel graphs). On the opposite, the sensitivity of FFT 
spectrum was not able to detect changes of sympathetic or parasympathetic tone at any of the frequency 
domain analyses studied (Fig. 3b, right panel graphs).
Eﬀects of methylatropine (peripheral muscarinic antagonist) on Morlet transform and Fast Fourier trans-
form of heart rate variability.
Methylatropine (muscarinic antagonist; vagolytic/anticholinergic) signiﬁcantly increased heart rate, while 
the arterial pressure was not altered (Fig. 4a).
While Morlet wavelet transform indices did not detected the peak time of methylatropine parasympathetic 
blockade, the FFT could detect it at LF and MF frequency domains (Fig. 4b).
5. Discussion
The present ﬁndings provide evidence that Morlet-wavelet transform indices may provide a sensitive 
measure to identify sympathetic and parasympathetic alterations of ANS. To our knowledge, our study is the 
ﬁrst to characterize the Morlet-wavelet transform indices in respect to the sympathetic and parasympathetic 
activities of ANS of which they might reﬂect. FFT method may be used to capture temporal aspects of HRV 
by analyzing a short segment of the signal at a time using a window of ﬁxed size and then sliding the window 
along in time. However, because FFT uses a ﬁxed-size window, at high periodicities it has a poor frequency 
resolution while at low periodicities the time resolution is poor. As a consequence, an FFT spectrum may 
give an inconsistent estimation of the periodicities and their temporal variations for a signal with multiple 
frequencies. Wavelet transform-based method provides an eﬃcient approach by which both the time and 
frequency resolutions can be adjusted in an adaptive fashion. It oﬀers high frequency resolution and low 
temporal resolution at high periodicities, and high temporal resolution and low frequency resolution at low 
periodicities.
Our study demonstrates that Morlet-wavelet transform of HRV can be a sensitive method to detect 
alterations of the ANS tone during cardiac sympathetic blockade, when the average HR is not signiﬁcantly 
altered. In our study, while metoprolol did not signiﬁcantly aﬀect HR, it induced alterations of its variability 
that could be detected by Morlet and not by FFT transfer method.
Alterations of the ANS tone during cardiac parasympathetic blockade were associated with a signiﬁcant 
increase of the average HR. The ANS control of the heart rate has normally the parasympathetic (cholinergic) 
component dominant, meaning that the heart is under a tonic vagal activity.
In summary, our study characterizes the use of Morlet wavelet transforms of heart rate variability for 
autonomic nervous system activity. Further translational studies to assess autonomic nervous system using 
the Morlet transform of HRV in clinical practice are envisaged.
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Fig. 3. (a) Eﬀects of metoprolol (β-adrenoceptor antagonist) on heart rate and mean arterial pressure. Data are mean with standard 
error; bpm = beats per minute; ∗p < 0.05. (b) Eﬀects of metoprolol (β-adrenoceptor antagonist) on Morlet transform and Fast 
Fourier transform of heart rate variability. Data are mean with standard error; nu = normalized units; ∗p < 0.05; ∗∗p < 0.01.
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Fig. 4. (a) Eﬀects of methylatropine (peripheral muscarinic antagonist) on heart rate and mean arterial pressure. Data are mean 
with standard error; bpm = beats per minute; ∗p < 0.05. (b) Eﬀects of methylatropine (peripheral muscarinic antagonist) on 
Morlet transform and Fast Fourier transform of heart rate variability. Data are mean with standard error; nu = normalized units; 
∗p < 0.05.
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